Therapetic targeting of Glucose pathways: Anticancer drug Epirubicin inhibits Glucose phosphate isomerase expression via up regulation of its target gene, 29/October/2013, 6.26 am

Therapeutic targeting of mammary cancer cell invasiveness: CEBP/β increases Junctional adhesion molecule A (JAM-A) expression via down regulation of its target gene, 28/October/2013, 8.24 am
November 28, 2013
Targeting intestinal cancer stem cells for cancer therapy: Anticancer drug Epirubicin inhibits Achaete scute-like 2 (Ascl2) expression via up regulation of its target gene, 29/October/2013, 6.34 am
November 29, 2013
Show all

Idea Proposed byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Therapetic targeting of Glucose pathways: Anticancer drugEpirubicin inhibits Glucose phosphate isomerase  expression via up regulation of its target gene, 29/October/2013, 6.26 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.